APS.TO
Aptose Biosciences Inc
Price:  
1.57 
CAD
Volume:  
22,405.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

APS.TO WACC - Weighted Average Cost of Capital

The WACC of Aptose Biosciences Inc (APS.TO) is 8.5%.

The Cost of Equity of Aptose Biosciences Inc (APS.TO) is 13.35%.
The Cost of Debt of Aptose Biosciences Inc (APS.TO) is 5.00%.

Range Selected
Cost of equity 9.80% - 16.90% 13.35%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.8% - 10.3% 8.5%
WACC

APS.TO WACC calculation

Category Low High
Long-term bond rate 3.3% 3.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.28 2.06
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.80% 16.90%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.8% 10.3%
Selected WACC 8.5%